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Summary
Emerging evidence suggests that cell senescence plays an
important role in aging-associated diseases including neurode-
generative diseases. HIV leads to a spectrum of neurologic
diseases collectively termed HIV-associated neurocognitive disor-
ders (HAND). Drug abuse, particularly methamphetamine (meth),
is a frequently abused psychostimulant among HIV+ individuals
and its abuse exacerbates HAND. The mechanism by which HIV
and meth lead to brain cell dysregulation is not entirely clear. In
this study, we evaluated the impact of HIV and meth on astrocyte
senescence using in vitro and several animal models. Astrocytes
constitute up to 50% of brain cells and play a pivotal role in
marinating brain homeostasis. We show here that HIV and meth
induce significant senescence of primary human fetal astrocytes,
as evaluated by induction of senescence markers (b-galactosidase
and p16INK4A), senescence-associated morphologic changes, and
cell cycle arrest. HIV- and meth-mediated astrocyte senescence
was also demonstrated in three small animal models (humanized
mouse model of HIV/NSG-huPBMCs, HIV-transgenic rats, and in a
meth administration rat model). Senescent astrocytes in turn
mediated neuronal toxicity. Further, we show that b-catenin, a
pro-survival/proliferation transcriptional co-activator, is down-
regulated by HIV and meth in human astrocytes and this
downregulation promotes astrocyte senescence while induction
of b-catenin blocks HIV- and meth-mediated astrocyte senes-
cence. These studies, for the first time, demonstrate that HIV and
meth induce astrocyte senescence and implicate the b-catenin
pathway as potential therapeutic target to overcome astrocyte
senescence.
Key words: HIV; methamphetamine; astrocyte; senescence;
b-catenin.
Introduction
With the introduction of combined antiretroviral therapy (cART), HIV has
been transformed from a deadly virus to a chronic infection linked to a
number of comorbid conditions associated with an aging population. In
particular, HIV-infected individuals are at an increased risk of neurocog-
nitive and motor impairments (Saylor et al., 2016) termed HIV-
associated neurocognitive disorders (HAND). Incidences of HAND are
expected to increase as the HIV+ population is living longer and aging.
HAND is driven by complex interactions of HIV invasion into the central
nervous system (CNS), inflammatory responses in the CNS that ensue,
and comorbid factors such as illicit drug abuse. Methamphetamine
(meth), in particular, is a potent psychostimulant (Hser et al., 2008) and
is frequently abused in the HIV/AIDS population. HAND is more severe
among HIV+ individuals who are meth abusers than those who are not
(Nath et al., 2002; Chana et al., 2006; Purohit et al., 2011). Further,
meth users who are HIV negative also experience neurocognitive deficits
that persist even following periods of abstinence from meth use (Scott
et al., 2007; Iudicello et al., 2010). The underlying mechanisms by which
HIV and meth dysregulate resident brain cells are not entirely clear. We
evaluated here the impact of HIV and meth on cellular aging in
astrocytes.
Astrocytes play a pivotal role in brain homeostasis. They are the major
source of storage for glucose and lactate for energy metabolism in
neurons. They are also responsible for > 90% of the uptake of the
extracellular neurotransmitter glutamate, which in excess is neurotoxic.
Astrocytes release a number of neurotrophic factors, regulate the
integrity of the blood–brain barrier, and contribute to immunity within
the CNS. Thus, dysfunctions of astrocytes will likely lead to disruption in
several brain functions. Further, there is an emerging recognition that
astrocytes play a significant role in neurodegenerative diseases. In many
of these neurodegenerative diseases, including HAND, reactive/activated
astrocyte is a hallmark feature of the disease. Both HIV encephalitis
brains and brains of meth abusers have increased levels of astrogliosis
(Langford et al., 2003). Reactive astrogliosis is also evident in the
striatum of a meth-treated rat model (Pu & Vorhees, 1993). While a
certain degree of astrocytosis is neuroprotective, overly reactive astro-
cytes compromise their protective properties such as alteration in ion
transport (Benos et al., 1994) and impaired glutamate transport (Wang
et al., 2003), which lead to harmful neuroinflammatory processes such
as increased levels of IL-1b, IL-6, and TNF-a (Minagar et al., 2002; Shah
et al., 2012).
Senescence is a cellular aging and stress response. The senescent cells
are characterized by their flat morphology in culture and expression of
senescence-associated b-galactosidase (SA-bGal) activity and p16INK4A
(Campisi, 2013). p16INK4A, also known as cyclin-dependent kinase
inhibitor 2A/multiple tumor suppressor 1, is an inhibitor of cyclin D-
dependent kinases such as CDK4 and CDK6. Activation of CDK4 and
CDK6 phosphorylates pRB and release of E2F thus promotes cell cycle
progression. Senescence may exhaust progenitor/stem cells and promote
inflammatory responses. Cellular senescence may also exacerbate age-
related phenotypes in vivo, as elimination of senescent cells in a
conditioned knockout mouse model effectively delays aging-associated
disorders (Baker et al., 2011). Human astrocytes can undergo senes-
cence in culture, exhibiting classical phenotypes of senescent cells such
as enhanced expression of SA-bGal, p16INK4A, and having a flat
morphology (Bhat et al., 2012). Astrocyte senescence may contribute
to brain aging (Kang et al., 2015) and neurodegenerative diseases such
as Alzheimer’s (Bhat et al., 2012) and Parkinson’s disease (Chinta et al.,
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2013). Although HIV induces cellular senescence of immune T cells,
contributing to dysfunction of T cells (Deeks et al., 2012), it is unclear
whether senescence plays a role in the dysfunction of HIV-infected brain.
Similarly, meth affects gene expression involved in cell cycle in human
primary astrocytes (Jackson et al., 2014); however, little is known about
the potential impact of HIV and meth on astrocyte senescence.
b-Catenin is a central mediator of the Wnt/b-catenin pathway. The
Wnt/b-catenin signaling pathway is vital to various functions in the CNS
including neurogenesis, neurotransmitter release, induction of long-term
potentiation and depolarization resulting in increased synaptic strengths,
and memory consolidation (Al-Harthi, 2012). Dysregulation of Wnt/b-
catenin signaling is linked to a number of neurodegenerative diseases,
including Alzheimer’s and Parkinson’s disease, and psychiatric disorders
such as bipolar disorder and depression (Al-Harthi, 2012; Berwick &
Harvey, 2012; Inestrosa et al., 2012; Levchenko et al., 2015). Astrocytes
secrete robust levels of Wnt ligands (Richards et al., 2015), which are
glycoproteins that bind to Frizzled receptors and the coreceptor
low-density lipoprotein receptor-related protein (LRP) 5/6 leading to
destabilization of the b-catenin destruction complex. Hypophosphory-
lated b-catenin translocates to the nucleus, where it interacts with TCF/
LEF to displace its corepressors and recruit either positive or negative
transcription cofactors to regulate Wnt target genes. We previously
demonstrated that endogenous Wnt/b-catenin signaling in astrocytes is
a restriction pathway to productive HIV replication. Suppression of b-
catenin relieves this transcriptional restriction to HIV and promotes
higher level of HIV replication in astrocytes. Further, HIV comorbid factor
meth suppresses b-catenin signaling in human primary fetal astrocytes
(HFAs; Sharma et al., 2011), which potentially could increase astrocyte
senescence. b-Catenin regulates cyclin D expression in human astrocytes
(Narasipura et al., 2012). Cyclin D-dependent CDK4 and CDK6 play a
critical role in cellular senescence. These collective observations suggest
that b-catenin may be an important determinant mediating HIV- and
meth-induced cell senescence in astrocytes.
Results
Meth and HIV induce senescence in primary human fetal
astrocytes (HFAs)
We first examined whether meth induces senescence of HFAs. human
fetal astrocytes were treated with a single dose of meth (0–1000 lM); at
day 6, HFAs were stained for SA-bGal. Meth significantly induced SA-
bGal expression even at the lower meth dose of 10 lM (Fig. 1A). The
greatest induction of SA-bGal was observed at 1000 lM meth, which
while excessive, during binges episodes, meth concentration could reach
165–776 lM in the brain (Talloczy et al., 2008). Further, meth-treated
HFAs demonstrated a classical flat morphology of senescent astrocytes
(Fig. 1B). Given that meth abusers commonly binge on meth in
consecutive days, we exposed HFAs to daily meth doses (0–300 lM)
for 5 days, and at day 6 after first meth treatment, SA-bGal expression
was measured. At lower doses of daily meth treatments (10–30 lM),
meth did not enhance SA-bGal expression above what was observed
with equivalent single-dose treatment (Fig. 1C). However, at higher
meth doses of daily treatment (100–300 lM), meth enhanced SA-bGal
expression in comparison with the single-dose treatment, as a daily
100 lM meth induced Sa-bGal at 8% higher than 100 lM single meth
dose (17% vs. 25%), a daily 300 lM meth 9% higher than 300 lM single
meth dose (31% vs. 22%). Meth also increased the expression of
another marker of cell senescence, p161NK4A, as evaluated by Western
blot (Fig. 1D). As senescent cells do not proliferate, we evaluated the
impact of meth on the cell cycle. HFAs were treated with a daily dose of
meth at 300 lM and at day 5 stained with EdU and PI. Meth reduced S
phase cells by twofold (11% vs. 21%) in comparison with vehicle-treated
cells, while induced cells in G1 phase by 16% (81% vs. 65%; Fig. 1E).
Together, these data demonstrate that meth induces cell senescence as
demonstrated by induction in biomarkers for cell senescence (SA-bGal
and p16INK4A) and cell cycle arrest.
To assess the impact of HIV on astrocyte senescence, HFAs were
either infected with a VSVG-pseudotyped HIVBaL (VSVG-HIV, 20 ng p24
per million cells) or mock infected. VSVG-HIV induced SA-bGal in HFAs
by fivefold (50% vs. 10%) in comparison with VSVG alone (Fig. 2A).
Infection of VSVG-HIV also caused a 1.8-fold increase in p16INK4A levels
(Fig. 2B). HFAs were also transfected with HIVBaL expression plasmid.
Transfection of HFAs with HIVBal plasmid induced SA-bGal
+ cells from
8% in pcDNA3 control plasmid to 20% in HIV-transfected cells (Fig. 2C).
To determine whether meth would increase senescence in HIV-infected
HFAs, HFAs were infected with VSVG-HIV (10 ng p24 per million cells)
and treated with a daily dose of meth at 300 lM for 5 days. While meth
alone and HIV alone induced SA-bGal expression by approximately 22%
in comparison with untreated cultures, together, they had an additive
effect on SA-bGal induction (Fig. 2D).
HIV and meth inhibit b-catenin signaling pathway
To assess the mechanism(s) that may be driving astrocyte senescence in
HIV infection and meth treatments of astrocytes, we evaluated the role
of b-catenin in these responses. We previously demonstrated that b-
catenin signaling is robustly expressed in astrocytes (Richards et al.,
2015) and, albeit in progenitor-derived human astrocytes, that meth and
HIV Tat suppress b-catenin signaling (Sharma et al., 2011; Henderson
et al., 2012). Wnt signaling pathway regulates senescence, as repression
of Wnt2 induced senescence in stressed primary human fibroblast WI38
cells (Ye et al., 2007) and knock-down of SFRP1 inhibited stress-induced
cell senescence (Elzi et al., 2012). We therefore evaluated whether
meth- and HIV-mediated downregulation of b-catenin signaling induces
cell senescence in HFAs.
Human fetal astrocytes (HFAs) were transiently transfected with a
Wnt/b-catenin signaling reporter plasmid, TOPflash. TOPflash consists of
several TCF/LEF DNA binding sites linked to firefly luciferase. TCF/LEF and
b-catenin bind to TCF/LEF DNA sequences to regulate gene expression.
Meth at 300 lM inhibited TOPflash activities by approximately 45%
(Fig. 3A). These data are consistent with meth inhibition of b-catenin
signaling in progenitor-derived astrocytes (PDAs) (Sharma et al., 2011).
HIV also inhibited b-catenin signaling in HFA, as demonstrated by
inhibition of active b-catenin expression post-VSVG-HIV infection to
30% at 48 h and 22% at 72 h of the VSVG control (Fig. 3B-C). These
data demonstrate that meth and HIV (not just HIV Tat) significantly
downregulate b-catenin signaling in HFAs.
b-catenin rescues human fetal astrocyte (HFA) from meth-
and HIV-induced senescence
To directly address whether downregulation of b-catenin induces cell
senescence in HFAs, HFAs were transfected with b-catenin siRNA or a
scrambled siRNA (Narasipura et al., 2012). Efficiency of b-catenin
knockdown is typically greater than 80% (Fig. 4A). Knockdown of b-
catenin induced SA-bGal expression by fourfold (40% vs. 9%) (Fig. 4B)
while knockdown of b-catenin together with meth increased SA-bGal
expression to 58%. To assess whether inducing b-catenin would block/
protect HFAs from either meth- or HIV-mediated cell senescence, HFAs
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were transfected with a constitutive active b-catenin plasmid or control
plasmid. This plasmid, S35Y b-catenin, has a serine at 35 to tyrosine
mutation preventing b-catenin phosphorylation by destruction complex
and subsequent proteasomal degradation. Induction of b-catenin
blocked meth-mediated HFA senescence by fivefold (Fig. 4C). Interest-
ingly, it also reduced basal levels of SA-bGal expression by threefold (3%
vs. 10%) without meth treatment. To induce b-catenin in HIV-infected
HFA, cells were treated with LiCl (5 mM), which induces b-catenin
expression by inhibiting GSK3b, a component of the b-catenin destruc-
tion complex. Treatment of HIV-infected HFAs with LiCl rescued SA-bGal
expression to baseline (approximately 6%, Fig. 4D). These data demon-
strate that induction of b-catenin rescues HFA from signals that induce
senescence in this case of either meth or HIV infection.
Senescent human fetal astrocytes (HFAs) induce
neurotoxicity
Senescent cells exhibit an altered profile of secreted cytokines and
chemokines, a phenomenon termed the senescence-associated secretion
phenotype (SASP), leading to inflammation and neurotoxicity. To explore
the consequence of astrocyte senescence on neurons, conditioned
media (CM) from senescent astrocytes were added to neurons.
Specifically, human LUHMES cells were differentiated into dopaminergic
neurons in vitro (Scholz et al., 2011) and HFAs were treated with meth
or vehicle (1xPBS) to induce senescence. The CM from HFAs was then
added to LUHMES neurons for 3 days. In parallel, a dose of 300 lM or
600 lM of meth was added directly to neurons cultures with fresh HFA
growth medium. Cells were stained with Hoechst dye to detect
apoptotic cell death. Direct addition of meth, at these doses, to neurons
did not induce cell death, a result consistent with previous report (Scholz
et al., 2011). However, HFA CM induced neuronal apoptosis by 25%
(Fig. 5 A and B), illustrating that astrocyte senescence induces neuronal
toxicity.
Astrocyte senescence in vivo
To determine whether astrocyte senescence occurs in vivo, we used IL-
2rcc-/- (NSG) mice reconstituted with human PBLs (huPBLs) and infected
with HIVBaL by i.p, as described (Richards et al., 2016). Three weeks
postinfection, the mice were sacrificed and the brains were analyzed for
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astrocyte senescence. HIV-infected NGF-huPBL mice exhibit enhanced
expression of GFAP and Iba1 (Fig. 6A) by 1.5- and fourfold, respectively,
in the hippocampus of HIV-infected mice in comparison with mock-
infected mice. Further, p16INK4A protein expression was elevated by
twofold in the hippocampus of HIV-infected mice in comparison with the
uninfected control brains (Fig. 6B). To specifically assess elevation of
p16INK4A in astrocytes of HIV-infected humanized mice, astrocytes were
isolated from mouse cortex and stained for GFAP and p16INK4A and
analyzed by flow cytometry. We demonstrated a twofold induction in
p16INK4A expression in astrocytes of HIV-infected mice in comparison
with mock-infected mice (Fig. 6C). In another HIV small animal model,
HIV-1 transgenic rat (HIV-Tg) (Reid et al., 2001), SA-bGal expression is
robust in the hippocampus of HIV-Tg at 6 weeks of age, in comparison
with non-Tg control (Fig. 6D).
To examinewhethermeth induces cell senescence in vivo, we utilized a
rat model that shows similar neuron damage seen in human meth users,
where the animal receives meth at 10 mg mL1, every 2 h for four times
(Halpin & Yamamoto, 2012). The striatum is most vulnerable to meth-
induced toxicity. We evaluated SA-bGal expression in striatum and
hippocampus. We observed that in the striatum, SA-bGal expression
was enhanced in meth-treated animals in comparison with the vehicle
control (Fig. 6E), whereas no difference was detected in the hippocampus
of meth-treated rats in comparison with vehicle-treated rats (data not
shown). Together, these data provide in vivo evidence using three animal
models to show that HIV and meth induce cell senescence in brain.
Discussion
Cell senescence and its associated SASP may drive premature organism
aging (Kennedy et al., 2014). Astrocyte senescence is implicated in
human brain aging (Kang et al., 2015) and in neurodegenerative
diseases such as Alzheimer’s (Bhat et al., 2012) and Parkinson’s disease
(Chinta et al., 2013). HAND exhibits many features of neuroinflamma-
tion, which is a common thread among a number of other premature
aging and neurodegenerative diseases, yet whether HIV neuroinvasion
impacts astrocyte senescence is not clear. We evaluated here the impact
of HIV and meth on astrocyte senescence. We show that both HIV and
meth induce astrocyte senescence as evaluated by enhanced expression
of senescence biomarkers such as SA-bGAL, p16INK4A, predominance of
cells in S phase of the cell cycle, and a flat morphology of astrocytes. The
HIV and meth effect on astrocyte senescence is additive in nature. Most
significantly, when astrocytes were induced into senescence by meth,
the conditioned medium increased neuronal apoptosis, which is consis-
tent with neuron damage in chronic meth abusers. Presumably, the
conditioned media of senescent astrocytes may either reflect a senes-
cence-associated secretion phenotype (SASP), which is characterized by
elevated levels of potent inflammatory cytokines (Campisi, 2013), or lack
key neurotrophic factors relevant to maintaining neuronal health. SASP
could also propagate senescence in a paracrine manner. In oncogene-
induced senescence models, both in vitro and in vivo, increased levels of
IL-1a induced SASP and senescence in neighboring cells (Acosta et al.,
2013). Thus, it is conceivable that meth- and HIV-induced senescence in
astrocytes would amplify senescence in neighboring astrocytes and even
neuronal stem cells in the surrounding regions.
Astrocytes are restricted to HIV infection in vitro. This restriction can
be overcome by priming astrocytes with IFN-c, which inhibits b-catenin
signaling in astrocytes, facilitating higher level of HIV replication
(Henderson et al., 2012). In studying the role of HIV in astrocyte
senescence, we were unable to prime astrocytes with IFN-c because IFN-
c alone led to astrocyte senescence (data not shown), suggesting that
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inflammatory cytokines, which are elevated in HAND, could also lead to
enhanced astrocyte senescence. Alternatively, we infected HFA with
VSVG-pseudotyped HIV or transfected the cells with HIV plasmid. Both
strategies demonstrated that HIV causes astrocyte senescence in vitro.
This is not an in vitro artifact, as astrocytes from HIV-infected humanized
mice also demonstrated astrocyte senescent phenotype through
increased expression of p16INK4A. Further, SA-bGal expression is elevated
in the brains of HIV-Tg rats and in meth-treated rat brains. Thus, our
in vitro and in vivo data support the concept that HIV and meth mediate
astrocyte senescence.
To assess approaches to protect/rescue astrocytes from senescence
mediated by meth or HIV, we focused on the Wnt/b-catenin signaling
pathway. Astrocytes have a robust endogenous expression of Wnt/b-
catenin signaling, which is a pro-survival/pro-proliferative pathway
(Henderson et al., 2012). Wnt signaling pathway regulates cell senes-
cence. A switch from b-catenin-dependent to b-catenin-independent
pathway in old mice resulted in senescence of hematopoietic stem cells
(Florian et al., 2013). Repression of Wnt2 expression triggers early onset
of senescence (Ye et al., 2007), while knockdown of Wnt signaling
inhibitor SFRP1 blocked stress-induced senescence (Elzi et al., 2012).
Using gain- and loss-of-function studies, we demonstrated that b-
catenin protects astrocytes from HIV/meth-mediated cell senescence. We
used LiCl as an inducer of b-catenin signaling in HIV-infected astrocytes,
instead of transfecting HIV-infected astrocytes with the constitutively
active b-catenin construct, because infected HFAs were fragile to
transfection attempts. Nonetheless, knocking down b-catenin in
uninfected astrocytes induced senescence and activation of b-catenin
by LiCl treatment of HIV-infected cells rescued them from cell
senescence.
b-catenin activities are central to the cell cycle, regulating multiple proteins
essential in the cell cycling such as c-Myc and Cyclin D in human astrocytes
(Narasipura et al., 2012).b-catenin also regulates the expressionof p16INK4A in
a cell context-dependent manner (Delmas et al., 2007; Bishop et al., 2010).
During the cell cycle, the active cyclin-dependent kinases CDK4 and CDK6
complexedwithcyclinDphosphorylateRBprotein.RBphosphorylationreleases
E2F transcription factors which activate the expression of genes promotingG1
to Sphase entry. Inactivationofb-cateninwoulddecrease levels of cyclinDand
blocks thecell entry toSphase.BydirectlybindingtoCDK4andCDK6,p16INK4a
blocks theassemblyofCDK4/6withcyclinDandtheiractivation, resulting inG1
phasearrest.p16INK4A isacritical regulator in the inductionof senescence.Thus,
Wnt/b-catenin signaling is central in cell senescence induced by cell stress such
as HIV infection and/or meth treatment.
Much attention is focused on direct neuronal injury in HIV and meth
comorbidity. Meth causes dopaminergic neuronal toxicity and HIV,
depending on stages of disease, can lead to neuronal toxicity or neuronal
injury manifested by neuronal pruning and synpatodendritic dysregula-
tion. Our study points to dysregulation of astrocytes, specifically
induction of astrocyte senescence in promoting neuronal injury. A
greater attention is needed to understand the role of astrocyte
senescence in disruption of astrocyte–neuronal communication as a
mechanism driving HIV/meth heightened neuropathogenesis and as a
common feature in neurodegenerative diseases.
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Experimental Procedures
Ethical statement of animal research
NOD/SCID/IL-2rcc-/- mice were purchased from The Jackson Laboratories
(Bar Harbor, ME; stock number 005557); adult male HIV-1 transgenic
Fischer F344 rats (HIV-1 Tg) and control Fischer F344 rats (non-Tg) at
3–4 weeks of age from Harlan Laboratory (Indianapolis, IN), and adult
male Sprague Dawley rats (180e275 g) from Harlan. The animals were
housed under pathogen-free conditions in accordance with the Institu-
tional Animal Care and Use Committee (IACUC #14-014, #13-048, and
#106095) at Rush University Medical Center and University of Toledo,
and the ethical guidelines for care of laboratory animals at the National
Institutes of Health.
Reagents
Methamphetamine (M8750), LiCl, BIO, and propidium iodide were
purchased from Sigma (St. Louis, MO). Access to meth was approved by
state and federal regulations. Senescence-associated b-galactosidase
(SA-bGal) kit and anti-GFAP G5 antibody were purchased from Cell
Signaling Inc (Danvers, MA). Other antibodies include Iba1 antibody
(Fisher Scientific #019-19741, Pittsburgh, PA), active b-catenin antibody
(US Biological C2069-47, Salem, MA), total b-catenin antibody (C2206;
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Sigma), p16INK4A antibody (Proteintech #22515-1-AP, Chicago, IL),
GAPDH antibody (G99445; Sigma), antineurofilament heavy chain
(Millipore Ab5539, Danvers, MA). Click-iT Plus EdU Alexa Fluor Flow
Cytometry Assay kit (C10646) was from Invitrogen (Waltham, MA).
Human fetal astrocytes (HFA) propagation and meth
treatment
HFAs (~18-week gestation, Lonza Inc, Walkersville, MD) were cultured in
complete astrocyte medium according to the supplier’s protocol. Early
passages (p2-p4) of HFAs were used for all experiments. For meth
treatment of HFAs, the cells were seeded in 8-well cell culture slide
chambers (Fisher Scientific, Rockford, IL). Media were changed the next
day, and the cells were treated with meth (0, 10, 30, 100, 300, 1000 lM)
or vehicle control (1xDPBS). Meth was added once or daily at specified
dose for 5 days, as indicated.
Human fetal astrocytes (HFA) infection with pseudotyped
HIV-1BaL virus
HIV-1 BaL strain (HIVBaL) was used in some experiments
Vesicular stomatitis virus (VSV)-G glycoprotein in trans with HIV-
1BaL virion (VSVG-HIV) were produced in 293T cells by cotransfection
of VSVG expression plasmid and HIVBaL plasmid in 293T cells using the
calcium precipitation method. The HIV-1BaL plasmid and VSV-G expres-
sion plasmid were obtained from the AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH. HFAs were infected with
VSVG-HIV at 10 ng or 20 ng of p24 overnight. Next day, cells were
washed extensively with 1xDPBS and cultured in fresh astrocyte medium.
Human fetal astrocytes (HFA) transfection of HIV-1BaL
expression plasmid
Human fetal astrocytes (HFAs) were transiently transfected with pHIV-
1BaL plasmid or control plasmid (pcDNA3) using Lipofectamine 2000
(Invitrogen). For experiments where HFAs were HIV-infected and meth-
treated, meth was added to the cells during infection and thereafter at
the specified concentrations.
Gain and loss of b-catenin function
To decrease b-catenin levels in HFAs, siRNA specific to b-catenin or a
scrambled control siRNA was transfected in HFAs using Lipofectamine
RNAiMAX reagent (Invitrogen) (Narasipura et al., 2012). To increase b-
catenin activities, a constitutively active b-catenin mutant (S35Y), or a
control plasmid (pcDAN3 + ) were transiently transfected using Lipofec-
tamine 2000 reagent (Invitrogen). LiCl at 5 mM was used to augment b-
catenin activities as described (Schenkel et al., 2010).
Senescence-associated b-galactosidase (SA-bGal)
cytochemical staining and quantitation
Senescence-associated b-galactosidase was detected by cytochemistry
using SA-bGal assay kit. Briefly, HFAs were washed with 1xDPBS, fixed
with 19 fixation solution for 10-15 min. After washing with 1xPBS
twice, the cells were stained with X-Gal containing staining solution at
37 °C overnight. Cells were then washed twice with 1xPBS, and covered
with 70% glycerol. Cells were imaged using a Zeiss invert microscope
with red, green, and blue channels under GRB setting. Acquired images
were analyzed in ImageJ software. SA-bGal+ cells as well as total cells
were counted. A minimal of 200 cells were counted per treatment. SA-
bGal+ senescent cells were quantified as percentage of total cells.
Western blotting analysis
HFAs and hippocampus tissues from human PBMC-reconstituted NSG
mice infected with HIV (see below) were lysed in 1xRIPA buffer in the
presence of protease inhibitors (Sigma). 10 lg of cell lysates was loaded
onto a 10% SDS-PAGE for detection of b-catenin and 20 lg lysates for
p16INK4A in 15% SDS-PAGE. Proteins were separated in the gel by
Tris–glycine system and transferred to a 0.45-um nitrocellulose paper.
The membrane was blocked with Pierce SuperBlock in PBS (Thermo
Scientific, Waltham, MA) plus 0.15% Tween-20 (Thermo Scientific) for
1 h at room temperature. Membranes were probed with primary
antibodies with indicated dilutions in SuperBlock TW20 (0.12%). Primary
antibodies used were as follows: rabbit anti-p16INK4A (1:500), mouse
monoclonal anti-active b-catenin antibody (1:1000), rabbit anti-b-
catenin antibody (1:50000), anti-GFAP (1:2000), Iba1 (1:500), anti-
synaptophysin (1:2000), anti-NF-H (1:2000), anti-GAPDH (1:50000).
Membranes, after overnight incubation with indicated dilutions of
primary antibodies in SuperBlock TW20 (0.12%), were washed three
times for 45 min with TBS-T and incubated with a 1:5000 dilution of
anti-mouse IgG or anti-rabbit IgG-HRP secondary antibody (Cell Signal-
ing, Boston, MA) in SuperBlock T20 (0.1%) for 1 h at room temperature.
Membranes were again washed three times for 45 min with TBS-T and
exposed to SuperSignal Femto ECL substrate reagent (Thermos Scientific)
for p16INK4A and active b-catenin, and SuperSignal Pico ECL substrate
reagent for total b-catenin and GAPDH. Films were exposed and
developed on a Konica SLX-101A auto processor. Band densitometry
was quantitated using ImageJ software (National Institutes of Health,
Bethesda, MD), using GAPDH as loading controls.
TOPflash assay
b-catenin-dependent transcription activities were analyzed using a T-cell
factor/lymphoid enhancer (TOPflash) reporter (Li et al., 2011). Transient
transfections of the TOPflash reporter plasmids were performed using
polyethylenimine reagent (Sigma). To circumvent the low infection rate
of HIV in HFAs, HIV expression plasmid was cotransfected together with
TOPflash plasmid to assess the effect of HIV on b-catenin activities.
Briefly, 1 lL of the transfection reagent was mixed with 100 lL of
serum-free media to which the recommended amount of DNA was
added (0.5 lg per 100 000 cells). The resulting transfection mix was
then incubated for 10 min at room temperature. Following the
incubation, the transfection mix was added to the cells. 48 h after
transfection, cells were lysed in 19 passive lysis buffer for 10 min. 20 lL
of lysate was used in a luciferase reporter assay (Promega, Madison, WI)
using a single injector luminometer. TOPflash activities were quantified
based on luciferin arbitrary units per lg of total cell lysate.
Cell cycle analysis
We adapted a cell cycle analysis using EdU Click-It Plus Flow Cytometry
kit (Invitrogen, CA) in combination with propidium iodide. Briefly, HFAs
were treated with 10 lM of EdU for 16 h. HFAs were fixed in 19 Click-
It fixature solution for 15 min and permeabilized in the 19 permeabi-
lization solution for 30 min in the dark. The Click-It reaction with
Alexa-594 was performed in a 100-lL reaction volume for 30 min.
Subsequently, a solution of 40 ng mL1 propidium iodide and
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0.2 mg mL1 RNase A was added to the cell pellet and the cells were
kept at 4 °C overnight in the dark. Cells were analyzed in DB
FASCCALIBUR, with Channel 594 for EdU. For the detection of PI with
Alexa-647, use 633/635-nm excitation with a red emission filter (660/
20 nm). Control cell samples for flow compensation analysis were
without either EdU labeling, propidium iodide, or both. All data were
analyzed in FlowJo software.
Reconstitution of NSG mice with human PBMCs and infection
with HIVBaL
These experiments were performed as described (Richards et al., 2016).
Six- to eight-week old NSG mice were injected with 2 9 107 human
PBMCs by intraperitoneal injection (i.p.). One to two weeks after
reconstitution, mice were bled by retro-orbital perfusion and extent of
reconstitution was determined by flow cytometry. Reconstituted mice
were infected with 104 TCID50/mouse of HIVBaL i.p.
Isolation of astrocytes from mouse brain
Mice were anesthetized by inhalation of isoflurane and then perfused
with 30–50 mL of ice-cold PBS. Brains were collected and the
hippocampus was lysed in 1xRIPA buffer for Western blotting analysis.
Astrocytes were isolated as described (Lovatt et al., 2007). Briefly, brains
were minced and digested with 8U mL1 papain (Invitrogen, Carlsbad
CA) and 80 kunitz units per mL DNase-1 (Invitrogen) in Ca2+/Mg2+-free
PIPES cysteine buffer (Sigma) for 1 h at 37°. After 1 h, an additional 25
kunitz units per mL DNase-1 was added for an additional 25 min.
Digestion was then massed through a 70-lM strainer with 1% BSA in
DMEM and then overlayed onto a layer of isotonic 90% Percoll
(Amersham, Piscataway, NJ) and spun at 200 g at 4 °C for 10 min. The
myelin and Percoll layers were collected and myelin was removed using
the Myelin Removal Bead Kit (Miltenyi Biotec, Cambridge, MA) accord-
ing to the manufacturer’s instructions.
Flow cytometric analysis
Single cell suspensions of cells isolated from mouse brain were stained
with LIVE/DEAD Fixable Violet Dead Cell Stain (Invitrogen) according to
the manufacturer’s instructions. Cells were washed with PBS and
stained for CD45-PE-Cy7 and CD11b-PE (BD Biosciences, San Jose, CA)
for 30 min at 4° and then washed two times in PBS. Cells were fixed
and permeabilized using BD Cytofix/Cytoperm (BD Biosciences) for
30 min at 4°. Cells were washed with Perm/Wash (BD Biosciences)
according to the manufacturer’s instructions. Cells were then stained
with rat anti-GFAP-Alexa Fluor 488 and rabbit anti-p16INK4A (Protein-
tech, Chicago, IL) in BD Perm/Wash for 30 min at 4°. Cells were
washed two times with BD Perm/Wash and then stained with an anti-
rabbit secondary antibody for the anti-p16INK4A conjugated to Alexa
Fluor 647 for 30 min at 4 °C. Cells were washed two times with BD
Perm/Wash and then one additional time with PBS before being run on
a BD Fortessa Flow Cytometer (BD Biosciences). Astrocytes were
identified as CD45loCD11bnegGFAP+ and 2000 live astrocytes were
collected. Flow cytometry was analyzed with FlowJo Analysis Software
(Tree star, Inc., Ashland, OR).
Meth treatment of rats
Adult male Sprague Dawley rats received meth (10 mg kg1, i.p.,
every 2 h 9 4) or saline control (1 mL kg1, i.p., every 2 h 9 4) as
described (Halpin & Yamamoto, 2012). All rats were sacrificed 7 days
after the treatment. This meth regimen was administrated based on
previous studies to show that it caused long-term neuronal damages
similar to those observed in human meth abusers (Halpin &
Yamamoto, 2012).
SA-bGal staining of rat brains
HIV-1 Tg and control non-Tg rats at 6 weeks of age, and rats of meth
treatment were sacrificed, and brains were fixed in 4% paraformalde-
hyde overnight. Brain tissues were sectioned at 40 lm thickness. Brain
sections were washed extensively in 1xPBS and then incubated in the
sodium citrate buffer (pH 6.0) at 45 °C for 2 h. SA-b-Gal staining of
these tissues was performed according to the manufacture’s protocol
(Cell Signaling).
Statistical analysis
Comparisons between groups depending on experiment were analyzed
using unpaired Student’s t-test, where appropriate. P values less than
0.05 were considered significant. All error bars are representative of
standard deviation within the sample group. Experiments were repeated
at least three times.
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